Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Recruiting

Registered drugNo placebo

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Atrial fibrillation

Not yet recruiting

Registered drug

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Obesity

Not yet recruiting

Investigational

KAI-9531 in Adults With Obesity or Overweight and Diabetes

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:HRS 9531

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Investigational

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational

Hungary

Participants:18–64 years · 65+ years

Contact Research Centre

Psoriatic arthropathy

Not yet recruiting

InvestigationalNo placebo

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Sonelokimab

Contact Research Centre

Atrial fibrillation

Not yet recruiting

Investigational

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Regn7508

Contact Research Centre

Obesity

Not yet recruiting

Investigational

Long‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide

Contact Research Centre

Heart failure with reduced ejection fraction

Not yet recruiting

Investigational

Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

Investigational

Hungary

Participants:18–64 years · 65+ years
Substances:Crd-4730

Contact Research Centre

Follicular lymphoma

Not yet recruiting

Registered drugNo placebo

Study of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Breast cancer

Not yet recruiting

Registered drugNo placebo

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo

Hungary

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Pneumonia

Not yet recruiting

Registered drug

Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

Registered drug

Hungary

Participants:18–64 years · 65+ years
Substances:Cholesterol

Contact Research Centre

Obesity

Not recruiting

Investigational

Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Investigational

Hungary

Participants:18–64 years · 65+ years

Contact Research Centre

Find therapies in clinical trials near you – page 5

163 trials match your criteria

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Atrial fibrillation

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Obesity

KAI-9531 in Adults With Obesity or Overweight and Diabetes

Arteriosclerosis

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Psoriatic arthropathy

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

Atrial fibrillation

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Obesity

Long‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes

Heart failure with reduced ejection fraction

Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

Follicular lymphoma

Study of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients

Breast cancer

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Pneumonia

Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

Obesity

Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.